Clinical Trial Update: Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating whether gene expression markers can predict outcomes in patients with diffuse large B-cell lymphoma treated with rituximab plus R-CHO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Deltasone (prednisone)
• Oncovin (vincristine)
• Rituxan (rituximab)

Snippet

Sponsor: University of Miami | Conditions: Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2017-06-23